The results showed that G1 had a lower aggressive pathological composition ratio, MDM2 and Ki67 expression, larger tumor size, and higher tumor microenvironment (TME) level compared to G2 (Figure 3E, G, H; Figure 3—figure supplement 1A and B). The gene discussed is MKI67; the disease is neoplasm.